Skip to main content

Animations

MJFF Publications

3941 - 3950 of 8818 Results
Title
Year
  • Year
  • 2025
  • 2018
  • 2018
  • 2015
  • 2019
  • 2018
  • 2015
  • 2018
  • 2019
  • 2013
  • Summary Details
    RESTRICTED
    Title: Reply to: “Early Indian Age at Onset of Parkinson's: A Case for a Gene‐Environment Lens”
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.70053
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Genetic variants related to urate and risk of Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.031
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Multi-objective particle swarm optimization for postoperative deep brain stimulation targeting of subthalamic nucleus pathways
    Journal Name: Journal of Neural Engineering
    Publisher: IOP Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1088/1741-2552/aae12f
    Citation Count: 37
  • Summary Details
    RESTRICTED
    Title: Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2015.03.008
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Immunotherapy in Parkinson’s disease: Current status and future directions
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104587
    Citation Count: 66
  • Summary Details
    RESTRICTED
    Title: Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.05.009
    Citation Count: 116
  • Summary Details
    OPEN
    Title: Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-015-0449-7
    Citation Count: 120
  • Summary Details
    OPEN
    Title: A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.001
    Citation Count: 119
  • Summary Details
    OPEN
    Title: Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.038
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral Organs
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc0
    DOI - Digital Object Identifier: 10.1371/journal.pone.0080705
    Citation Count: 180
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.